Month-to-month vs annual GLP-1 programs: read the commitment evidence

Frequently asked questions

Does a per-month price always mean month-to-month billing?

No. A rate expressed per month can be attached to an annual, yearly, or 12-month plan. The label helps normalize cost across time, but it does not state how much is collected today, whether the full term is prepaid, or how later charges are scheduled. Keep the duration qualifier beside every number and request the current checkout calendar before treating it as a flexible monthly purchase.

What does yourEra's no-long-term-contract record establish?

The accepted row says yourEra is best for transparent self-pay pricing without a stated long-term contract. Its starting-price field lists compounded semaglutide from $99 per month and compounded tirzepatide from $169 per month. That wording does not establish a cancellation cutoff, refund rule, renewal date, or treatment of an order already in process. Those fields remain outside this comparison unless supplied in current terms.

How should I read Trimi's $99 and $125 figures?

Trimi's accepted price field states compounded semaglutide from $99 per month and compounded tirzepatide from $125 per month on annual plans. The annual-plan qualifier is inseparable from both prices. The row does not provide a general service timeline: average wait is Not stated. This page does not calculate a yearly total or assume how the annual obligation is billed.

What is known about Gala GLP-1's yearly-plan figure?

Gala GLP-1's accepted row states compounded GLP-1/GIP advertised from $179 per month on a yearly subscription plan. Its best-for field describes a stated flat monthly figure across dose levels on a yearly plan. The row also says the shipping fee was not stated on the scraped page. No payment schedule, cancellation right, refund eligibility, or renewal mechanic is added here.

Why is HealthRX's $99 figure not treated as month-to-month?

HealthRX advertises from $133 per month, and its checked page also references $99 per month on a 12-month plan. The accepted limitation explicitly says a 12-month rate is not a month-to-month quote. This comparison therefore keeps $99 attached to 12 months and does not substitute it for the $133 starting statement or infer the amount due at checkout.

What is the safest way to compare commitment exposure and preserve a complete source trail?

Write one line for each selected offer: product wording, advertised monthly rate, stated plan duration, amount due today, dates of later charges, renewal date, and total scheduled obligation. The first three fields come from the accepted evidence here; the remaining fields must come from current checkout terms. If a field is unavailable, write Not stated rather than converting a monthly label into an assumed payment schedule. Date every captured page and keep the selected offer separate from other products sold by the same program. Record whether each entry came from the public page, the cart, or a written response. If terms change between those locations, preserve both versions and ask which document governs before payment. This provenance trail is more useful than a single calculated monthly average because it shows exactly where the commitment evidence ends.

Can this page tell me whether I can cancel, receive a refund, or change a published plan term?

No. The accepted evidence does not establish cancellation rights or refund eligibility across these four offers. No-contract language, an annual-plan label, a yearly-plan label, and a 12-month rate are not complete cancellation policies. Ask for the operative terms, effective cutoff, renewal handling, order status, and written acknowledgment, but do not assume any answer from the plan label alone.

Why are public-review scores zero?

All four rows receive zero public-review points under the frozen rubric. No comparable independent review dataset was verified for this accepted set. That zero is an evidence-scoring decision; it is not a statement that customers have never discussed the programs. Provider testimonials or ratings are not converted into review points here.

Does the score identify the clinically best program?

No. Scores measure the accepted public commercial evidence under a frozen rubric. A higher score does not establish better care, medical appropriateness, medication quality, speed, or outcomes. Prescription decisions belong to licensed clinicians. Every row remains an evidence comparison and does not establish medical suitability.